# Study To Assess Long Term Safety Of Pazopanib

> **NCT00387205** · PHASE1 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 188 (actual)

## Conditions studied

- Carcinoma, Renal Cell

## Interventions

- **DRUG:** Pazopanib

## Key facts

- **NCT ID:** NCT00387205
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06-20
- **Primary completion:** 2013-02-13
- **Final completion:** 2018-03-08
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2019-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00387205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00387205, "Study To Assess Long Term Safety Of Pazopanib". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00387205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*